Tamar Ben-Yedidia

Tamar Ben-Yedidia is currently the Chief Scientific Officer at BiondVax Pharmaceuticals Ltd. They have extensive experience in managing preclinical and clinical studies, including Phase I/II and Phase II trials. Prior to their current role, they worked as a Professor Assistant at Weizmann Institute of Science and as an R&D Lab Manager at Biotechnology general. Tamar holds a Ph.D. in Immunology from Weizmann Institute of Science and an MSc in Immunology from Tel Aviv University.